Bone Marrow (BM), using the Next Generation Sequencing (NGS). The mutated genetic, checked in both cfDNA and BM, were monitored at the different time points during the treatment by droplet ... patients detected DNMT3A…
crucial for risk assessment, medication selection and ongoing therapeutic monitoring in AML, it is important to obtain the NPM1 mutation Copy Number (CN). The aim of this work
Applications of liquid biopsy are primarily to monitor treatment response and to detect secondary treatment resistant mutations. In patients with bone-dominant metastatic breast cancer it can be challenging
crucial for risk assessment, medication selection, and ongoing therapeutic monitoring in AML4,5, it is important to obtain the NPM1 mutation copy number (CN). The aim of this work
Serial monitoring of circulating tumor DNA may predict resistance to first-line epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors before CT-confirmed progression. Our objective was to evaluate dynamic…
long term follow-up monitoring system was used in order to detect somatic mutations and chromosomal damages caused by environmental and occupational mutagens and carcinogens in the peripheral blood lymphocytes
CSF1 and IL-34, two cytokines mediating macrophage production, differentiation and activation. CSF1R mutations are already described as risk factors for myeloid neoplasms. Discussion: We detected a new PFS candidate…
cancer patients, mutational analysis is necessary. Especially, status of epidermal growth factor receptor (EGFR) mutations is very important factor of non-small cell lung cancer (NSCLC) diagnosis. Circulating cell-free…
that contribute to the different types of blood cancers. These mutations can be used for the diagnostic classification and monitoring but in acute myeloid leukemia (AML) and with the exception ... novel targeted…
viral load determination and drug resistance mutations in HIV-2 strains in patients in Ghana. The results indicate the need for continuous monitoring of HIV-2 drug resistance to improve
helpful in breast cancer diagnostic and monitoring of therapy. Next generation sequencing for somatic tumour specific mutations like PI3K or TP53 gene mutations in circulating cf DNA has successfully demonstrated
multiple cancers, including bladder cancer. Thus, selective determination of such mutations can improve early diagnostics of cancer and monitoring of cancer progression and treatment. Main limitations for existing…
ddPCR enables a range of important genomic applications, including cancer mutation detection, gene copy number determination, viral load monitoring, gene edit detection and CRISPR. The high sensitivity, specificity and…
Monitoring phenotype changes and linking them with potential genetic mutations has becoming an important tool for building disease models and developing biomarkers and disease diagnosis methods. Phenotypic analysis of…
quantitative PCR. The incidence of thrombus was monitored and blood and coagulation were routinely assayed in patients with MPN. The JAK2V617F mutation was found in 8/68 individuals
aided epidemiological studies of infectious disease outbreaks and the monitoring of infection treatment outcomes, particularly for viruses that mutate often. The applications of qualitative and quantitative real-time…
rare genetic disorder, with varied symptoms, signs, requiring careful monitoring for potential complications. It is due to sickle mutation and thalassemia mutation occurring together, with sparse data available worldwide
remains the standard protocol to monitor drug resistant strains. More than 90% of rifampicin resistant M. tb has been shown to be caused by mutations inside the 81-bp rifampicin
apparently healthy father; mother and only sister did not carry the mutation. C634R mutation has been described and found specifically in cases of MEN2A. This is why; the search ... well as a biological and medical…
understand the mechanisms of response and resistance to various cancer treatments. Although current immune monitoring strategies pose clinical challenges, advances in approaches and techniques are improving our ability…
understand the mechanisms of response and resistance to various cancer treatments. Although current immune monitoring strategies pose clinical challenges, advances in approaches and techniques are improving our ability…
group M circulating in Kinshasa, the prevalence of mutations associated with resistance to antiretroviral treatment and their involvement in therapeutic monitoring of infected patients followed in different centers…
circulating tumor DNA and identify mutations in genes associated with cancer at a very low allelic frequency. The test can be used for the monitoring of cancer remission after treatment